Connecticut General Statutes/Title 20/Chapter 400j/Section 20-618

CGS § 20-618. (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.

Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.

Short History

(P.A. 79-116, S. 2; P.A. 95-264, S. 39.)

Long History

History: Sec. 19-226a transferred to Sec. 21a-107 in 1983; P.A. 95-264 made technical changes; Sec. 21a-107 transferred to Sec. 20-618 in 1997.

PreviousCGS § 20-617b. Compliance packaging. Requirements. Regulations.NextCGS § 20-619. (Formerly Sec. 20-185a). Substitution of generic drugs and biological products. Definitions. Interchangeable biological products. Prescribing practitioners. Pharmacy signs. Dispensing. Records. Regulations.